RARE: Ultragenyx Pharmaceutical Inc. Company Aggregate Debts

Brandmark of Ultragenyx (RARE)

Ultragenyx Pharmaceutical (RARE) possesses monopoly pricing power due to its unique drugs for treating rare pathologies. The development of new medications is accelerating through strategic alliances with research centers. Full patient loyalty is ensured by the lack of alternatives in this niche. Current debt levels on this GURU.Markets chart show that the indicator stands at 0.00.

Company Debts: Ultragenyx Corp (RARE) for 07/04/2022 - 11/01/2026

Metric breakdowns and analytics for Ultragenyx (RARE)

- stock price and consensus target price:
Share Price Ultragenyx Corp|RARE - Analyst Consensus Forecast
- market capitalization information:
Market Capitalization Ultragenyx Pharma|RARE - Real Price to Acquire Entire Company
- balance sheet equity data:
Book Value per Share Ultragenyx|RARE - Company Book Value|Market Value to Book Value Ratio ultragenyx.com|RARE - Cumulative Company Assets
- business debt structure and liquidity details:
Aggregate Debt to Capital Ultragenyx Pharmaceutical|RARE - Long-Term Debt to Equity|Ratio of Short-Term Indebtedness to Capital Ultragenyx Pharmaceutical Inc.|RARE - Company Aggregate Debts|Debts to Book Capitalization Ultragenyx Pharma|RARE - Company Long-Term Debts|Short-Term Indebtedness Ultragenyx|Immediate Liquidity ultragenyx.com
- company profitability and valuation multiples indicators:
RARE - Company Net Income
General company analysis:RARE Ultragenyx Corp
Brand item of Ultragenyx Pharmaceutical Inc.

This indicator captures the aggregate of bank loans and liabilities to creditors, measuring the company's capital management efficiency and debt load. By analyzing the total volume of debt, investors assess the financing stability of Ultragenyx Pharmaceutical (RARE), which, combined with the management's reputation and their regulatory successes, confirms the strategic justification of borrowed funds for the development of orphan drugs.

Competing companies

Tempus AI, Inc. - Company Aggregate Debt|Company Aggregate Debts QGEN (Qiagen N.V.)|Company Aggregate Debts ionispharma.com IONS|RGEN: Company Total Debt|RNA - Company Aggregate Debts|CRISPR Therapeutics Corp (CRSP) - Company Debts|WGS (GeneDx Corp) - Company Debts|Company Total Debt BEAM|SRPT (sarepta.com) - Company Cumulative Indebtedness|Company Debts Twist Bioscience, Inc. (TWST)|TXG (10x Genomics Inc) - Aggregate Debt Obligations|Company Aggregate Debts NTLA (Intellia)|Company Aggregate Debts Stoke Corp STOK|BioLife Solutions, Inc. - Company Aggregate Debts|Company Total Indebtedness wavelifesciences.com (WVE)|MAZE: Company Aggregate Debts|Company Cumulative Debt Sionna Therapeutics, Inc. (SION)|Company Debts Prime Medicine Corp|Company Aggregate Debt TSHA (Taysha Corp)|Company Total Debt QURE (uniQure N.V.)|MGTX - Company Cumulative Debt|REGENXBIO - Company Total Debt|SLDB: Company Aggregate Debt|OCGN: Company Total Debt|Aggregate Debt Obligations PACB (PacBio Corp)|Benitec Biopharma Inc. (BNTC) - Company Debts|Company Aggregate Indebtedness DSGN (designtx.com)|RCKT (Rocket Pharmaceuticals, Inc.) - Company Aggregate Debts|FDMT: Aggregate Debt Obligations|Company Aggregate Debts LXEO|Company Aggregate Debts korrobio.com (KRRO)|Company Debts Editas Medicine, Inc. EDIT|Aggregate Debt Obligations SLN|PRQR - Company Debts|Codexis, Inc. (CDXS) - Company Total Debt|SGMO: Company Aggregate Debts|Nautilus Bio (NAUT) - Company Aggregate Debts|MGX (Metagenomi, Inc.) - Company Aggregate Debts|Company Total Debt precisionbiosciences.com (DTIL)|Company Aggregate Debts GBIO|BOLD - Company Cumulative Debt|Exicure - Company Total Debt|Company Aggregate Debts Imunon Inc IMNN|PHIO: Company Total Debt|Mustang Bio, Inc. - Company Cumulative Indebtedness|RNAZ: Company Aggregate Debts|BNGO - Company Total Debt Obligations|APDN (Applied DNA) - Company Aggregate Debts|Company Total Debt bluebird bio, Inc (BLUE)|Company Aggregate Debts IPA|Company Aggregate Debts omegatherapeutics.com (OMGA)|Company Debts Singular Genomics OMIC|Regulus Therapeutics, Inc. - Company Debts|SYRS - Company Debts|Aggregate Debt Obligations TBIO (Telesis Bio, Inc)|TCON: Company Aggregate Debts|unitybiotechnology.com (UBX) - Company Aggregate Debts